Clinical Trial Update: Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immune response to different schedules of a tetravalent dengue vaccine given with or without yellow fever vaccine; results posted after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue
• Dengue Fever
• Dengue Hemorrhagic Fever
• Yellow Fever

Drugs mentioned

• Tetravalent dengue vaccine
• Yellow fever vaccine (live attenuated yellow fever vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Dengue, Dengue Fever | Phase 2 | Status: COMPLETED | Results posted: 2019-06-14